MWK Healthcare are delighted to announce the launch of Provocholine in the UK
Provocholine® (methacholine chloride) is indicated for the diagnosis of bronchial airway hyperresponsiveness in subjects who do not have clinically apparent asthma.
The Provocholine® Challenge provides for a sensitive and generally accurate diagnosis of bronchial hyperreactivity as well as the severity of asthma. The Provocholine® Challenge can also be used to confirm occupational asthma.
For more information please go to the dedicate product web site. www.provocholine.co.uk